Endoscopic Therapy Or Surgery for Early Colon Cancer

The trial is a randomized head-to-head comparison of the benefits, harms and burdens of endoscopic full-thickness resection (eFTR), a novel, minimally invasive endoscopic treatment modality, for early colon cancer as compared to standard-of-care surgery.

NCT Number	NCT06940947
Lead Sponsor	Norwegian Department of Health and Social Affairs Collaborators: Medical University of Gdansk, Vestre Viken Hospital Trust, Universitätsklinikum Hamburg-Eppendorf, Institute of Oncology in Warsaw, Karolinska Institutet, University Hospital, Limoges, University Hospital, Akershus, University of Roma La Sapienza, Hospital Clinic of Barcelona, Leuven University Medical Center, University Hospital, Ghent, Sorlandet Hospital HF, Northern Norway Regional Health Trust, Helse Stavanger HF, Haukeland University Hospital, St. Olavs Hospital, University of Oslo, Frontier Science Foundation
Conditions	Colon Cancer
Enrollment	434 participants
Start Date	2025-08-25
Primary Completion	2033-09-01 (estimated)
Study Completion	2033-09-01 (estimated)
Updated on ClinicalTrials.gov	2025-11-20